Table 2.
Eosinophilic gastritis | |||
---|---|---|---|
Biopsy site | N | Mean eosinophil count | Range |
Stomach | |||
Overall | 105 | 86.7 | 13–500 |
Fundus | 12 | 48.2 | 20–100 |
Body | 40 | 86.7 | 13–400 |
Antrum | 64 | 78.4 | 13–400 |
Unspecified site | 27 | 120 | 15–500 |
Eosinophilic gastroenteritis | |||
Biopsy site | N | Mean eosinophil count | Range |
Stomach | |||
Overall | 54 | 78.3 | 6–500 |
Fundus | 9 | 58.2 | 14–100 |
Body | 19 | 79 | 6–404 |
Antrum | 34 | 74.8 | 12–404 |
Unspecified site | 9 | 112.3 | 23–500 |
Small intestine | |||
Overall | 45 | 64.9 | 12–200 |
Duodenum | 38 | 61.1 | 12–182 |
Jejunuma | 3 | 76.7 | 25–140 |
Ileuma | 10 | 73.6 | 32–200 |
Eosinophilic colitis | |||
Biopsy Site | N | Mean eosinophil count | Range |
Colon | |||
Overall | 80 | 75.6 | 10–500 |
Right colon | 49 | 75.1 | 9–500 |
Left colon | 55 | 64.1 | 10–350 |
Rectosigmoid colon | 37 | 38.9 | 3–135 |
Unspecified site | 14 | 78.8 | 30–168 |
Data shown as number (N) of population. Peak tissue eosinophil counts are expressed per high-power field (hpf), including mean peak eosinophil count and range of eosinophils/hpf
For subjects with a clinical diagnosis of EGE, 36 (29%) had quantified eosinophils in both the stomach and small intestine